Albuminuria linked to dementia
Albuminuria is associated with a 35 per cent increased risk of cognitive impairment or dementia, according to a meta-analysis of 22 studies published in Neurology.
The meta-analysis included studies that followed at least 100 people aged 45 years and older for a year or more. Based on five of these studies involving 27,805 people, albuminuria was associated with an increased risk of more than a third of cognitive impairment or dementia.
The 28 per cent increase in cognitive impairment or dementia seen in people with an estimated glomerular filtration rate (eGFR) of less than 60ml/min/1.73m2 did not reach statistical significance.
A lack of high-quality data meant the authors could not perform meta-analyses for serum creatinine, creatinine clearance or cystatin C, a protein that seems to be neuroprotective. Nevertheless, there was â€œtentative evidenceâ€ of an association between elevated serum creatinine levels and cognitive impairment and dementia.
â€œKidney dysfunction has been considered a possible risk factor for cognitive impairment or dementia,â€ says study author Kay Deckers from Maastricht University in the Netherlands. â€œChronic kidney disease and dementia share many risk factors, such as high blood pressure, diabetes and high cholesterol, and both show similar effects on the brain, so they may have shared vascular factors or there may even be a direct effect on the brain from kidney problems.
â€œMore research is needed to determine whether the kidney problems are a cause of the cognitive problems or if they are both caused by the same mechanisms.â€
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Diabetes screening costs in pharmacy similar to GPs
The economic analysis used data collected from 172 patients from six pharmacies in Leicester and 164 patients from six pharmacies in Surrey.
1 Min Article
Status epilepticus: why rapid, aggressive treatment is essential
In contrast to typical epilepsy seizures, untreated SE can last an hour or more, increasing the risk of serious complications.
3 Min Article
Hydroxychloroquine 'ineffective in treating Covid-19'
Preliminary results from RECOVERY trial show hydroxychloroquine has no effect on mortality.
1 Min Article
Let's talk tech: Using technology to drive your business
This training offers insights into making the most of technology and the commercial opportunities this can offer your business.
8 Min Module
Covid-19 and mental health
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.
4 Min Module
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
10 Min Module